Intrauterine adhesion (IUA), a prevalent cause of female infertility and recurrent pregnancy loss, is characterized by endometrial trauma and progressive fibrosis. Current treatment modalities, including hysteroscopic adhesiolysis and hormone decidual multipotent mesenchymal stromal cells (DMSCs), a unique subset of stromal cells derived from the endometrium, exhibit strong multipotent differentiation capabilities, immunomodulatory properties, and low immunogenicity. These features enable DMSCs to facilitate endometrial regeneration, restore intrauterine immune homeostasis, and attenuate fibrosis, offering a compelling therapeutic strategy for IUA. Recent preclinical studies have demonstrated promising regenerative outcomes, yet the clinical application of DMSCs remains constrained by challenges such as limited cell availability, variability in therapeutic efficacy, and concerns regarding long-term safety. This review provides a comprehensive overview of the current progress in DMSC-based therapy for IUA, highlights its mechanistic advantages, and discusses critical obstacles and future directions for successful clinical translation.
LeeWL, LiuCH, ChengM, et al.Focus on the primary prevention of intrauterine adhesions: Current concept and vision. Int J Mol Sci, 2021; 22:5175; doi: 10.3390/ijms22105175
2.
The American Fertility Society. Classifications of adnexal adhesions, distal tubal occlusion, tubal occlusion secondary to tubal ligation, tubal pregnancies, müllerian anomalies and intrauterine adhesions. Fertil Steril, 1988; 49:944–955.
3.
DongyunY, LiY. The value of modified transvaginal real-time three-dimensional hysterosalpingography ultrasound technique combined with hydro hysterosalpingography for evaluating intrauterine adhesions in infertility patients. Chin J Fam Plan Gynecotokol, 2020; 28.
4.
KurodaK, YamanakaA, TakamizawaS, et al.Prevalence of and risk factors for chronic endometritis in patients with intrauterine disorders after hysteroscopic surgery. Fertil Steril, 2022; 118:568–575; doi: 10.1016/j.fertnstert.2022.05.029
5.
LinX, FangY, MiX, et al.Intrauterine injection of bioengineered hydrogel loaded exosomes derived from HUCM stem cells and spermidine prominently augments the pregnancy rate in thin endometrium rats. Regen Ther, 2024; 27:63–72; doi: 10.1016/j.reth.2024.02.003
6.
BlancoO, TiradoI, Muñoz-FernándezR, et al.Human decidual stromal cells express HLA-G: Effects of cytokines and decidualization. Hum Reprod, 2008; 23:144–152; doi: 10.1093/humrep/dem326
7.
CastrechiniNM, MurthiP, QinS, et al.Decidua parietalis-derived mesenchymal stromal cells reside in a vascular niche within the choriodecidua. Reprod Sci, 2012; 19:1302–1314; doi: 10.1177/1933719112450334
8.
SunH, DongJ, FuZ, et al.TSG6-Exo@CS/GP attenuates endometrium fibrosis by inhibiting macrophage activation in a murine IUA model. Adv Mater, 2024; 36:e2308921; doi: 10.1002/adma.202308921
9.
YangJH, ChenMJ, ChenCD, et al.Optimal waiting period for subsequent fertility treatment after various hysteroscopic surgeries. Fertil Steril, 2013; 99:2092–2096.e3; doi: 10.1016/j.fertnstert.2013.01.137
10.
GargettCE, SchwabKE, DeaneJA. Endometrial stem/progenitor cells: The first 10 years. Hum Reprod Update, 2016; 22:137–163; doi: 10.1093/humupd/dmv051
11.
ChanRW, SchwabKE, GargettCE. Clonogenicity of human endometrial epithelial and stromal cells. Biol Reprod, 2004; 70:1738–1750; doi: 10.1095/biolreprod.103.024109
12.
LiuL, ChenG, ChenT, et al.si-SNHG5-FOXF2 inhibits TGF-β1-induced fibrosis in human primary endometrial stromal cells by the Wnt/β-catenin signalling pathway. Stem Cell Res Ther, 2020; 11:479; doi: 10.1186/s13287-020-01990-3
13.
XiongZ, MaY, HeJ, et al.Apoptotic bodies of bone marrow mesenchymal stem cells inhibit endometrial stromal cell fibrosis by mediating the Wnt/β-catenin signaling pathway. Heliyon, 2023; 9:e20716; doi: 10.1016/j.heliyon.2023.e20716
14.
LiuF, ZhuZJ, LiP, et al.Creation of a female rabbit model for intrauterine adhesions using mechanical and infectious injury. J Surg Res, 2013; 183:296–303; doi: 10.1016/j.jss.2012.11.009
15.
LiB, ZhangQ, SunJ, et al.Human amniotic epithelial cells improve fertility in an intrauterine adhesion mouse model. Stem Cell Res Ther, 2019; 10:257; doi: 10.1186/s13287-019-1368-9
16.
NingJ, ZhangH, YangH. MicroRNA-326 inhibits endometrial fibrosis by regulating TGF-β1/Smad3 pathway in intrauterine adhesions. Mol Med Rep, 2018; 18:2286–2292; doi: 10.3892/mmr.2018.9187
17.
LinY, DongS, ZhaoW, et al.Application of hydrogel-based delivery system in endometrial repair. ACS Appl Bio Mater, 2020; 3:7278–7290; doi: 10.1021/acsabm.0c00971
18.
ZhangZ, LiS, DengJ, et al.Aspirin inhibits endometrial fibrosis by suppressing the TGF-β1-Smad2/Smad3 pathway in intrauterine adhesions. Int J Mol Med, 2020; 45:1351–1360; doi: 10.3892/ijmm.2020.4506
19.
YaoY, ChenR, WangG, et al.Exosomes derived from mesenchymal stem cells reverse EMT via TGF-β1/Smad pathway and promote repair of damaged endometrium. Stem Cell Res Ther, 2019; 10:225; doi: 10.1186/s13287-019-1332-8
20.
XueX, ChenQ, ZhaoG, et al.The overexpression of TGF-β and CCN2 in intrauterine adhesions involves the NF-κB signaling pathway. PLoS One, 2015; 10:e0146159; doi: 10.1371/journal.pone.0146159
21.
FletcherNM, JiangZL, DiamondMP, et al.Hypoxia-generated superoxide induces the development of the adhesion phenotype. Free Radic Biol Med, 2008; 45:530–536; doi: 10.1016/j.freeradbiomed.2008.05.002
22.
ZhangY, LinX, DaiY, et al.Endometrial stem cells repair injured endometrium and induce angiogenesis via AKT and ERK pathways. Reproduction, 2016; 152:389–402; doi: 10.1530/REP-16-0286
23.
WangX, MaN, SunQ, et al.Elevated NF-κB signaling in Asherman syndrome patients and animal models. Oncotarget, 2017; 8:15399–15406; doi: 10.18632/oncotarget.14853
24.
CousinsFL, MurrayA, EsnalA, et al.Evidence from a mouse model that epithelial cell migration and mesenchymal-epithelial transition contribute to rapid restoration of uterine tissue integrity during menstruation. PLoS One, 2014; 9:e86378; doi: 10.1371/journal.pone.0086378
25.
HuJ, ZengB, JiangX, et al.The expression of marker for endometrial stem cell and fibrosis was increased in intrauterine adhesious. Int J Clin Exp Pathol, 2015; 8:1525–1534.
26.
DuH, TaylorHS. The role of Hox genes in female reproductive tract development, adult function, and fertility. Cold Spring Harb Perspect Med, 2015; 6:a023002; doi: 10.1101/cshperspect.a023002
27.
ZhouQ, WuX, HuJ, et al.Abnormal expression of fibrosis markers, estrogen receptor α and stromal derived factor-1/chemokine (C-X-C motif) receptor-4 axis in intrauterine adhesions. Int J Mol Med, 2018; 42:81–90; doi: 10.3892/ijmm.2018.3586
28.
DuX, YuanQ, QuY, et al.Endometrial mesenchymal stem cells isolated from menstrual blood by adherence. Stem Cells Int, 2016; 2016:3573846; doi: 10.1155/2016/3573846
29.
HuaQ, ZhangY, LiH, et al.Human umbilical cord blood-derived MSCs trans-differentiate into endometrial cells and regulate Th17/Treg balance through NF-κB signaling in rabbit intrauterine adhesions endometrium. Stem Cell Res Ther, 2022; 13:301; doi: 10.1186/s13287-022-02990-1
30.
ChenY, ChangY, YaoS. Role of angiogenesis in endometrial repair of patients with severe intrauterine adhesion. Int J Clin Exp Pathol, 2013; 6:1343–1350.
31.
XiaoL, ZhuH, ShuJ, et al.Overexpression of TGF-β1 and SDF-1 in cervical cancer-associated fibroblasts promotes cell growth, invasion and migration. Arch Gynecol Obstet, 2022; 305:179–192; doi: 10.1007/s00404-021-06137-0
32.
SabapathyV, KumarS. hiPSC-derived iMSCs: NextGen MSCs as an advanced therapeutically active cell resource for regenerative medicine. J Cell Mol Med, 2016; 20:1571–1588; doi: 10.1111/jcmm.12839
33.
PharounJ, BerroJ, SobhJ, et al.Mesenchymal stem cells biological and biotechnological advances: Implications for clinical applications. Eur J Pharmacol, 2024; 977:176719; doi: 10.1016/j.ejphar.2024.176719
34.
KyurkchievS, ShterevA, DimitrovR. Assessment of presence and characteristics of multipotent stromal cells in human endometrium and decidua. Reprod Biomed Online, 2010; 20:305–313; doi: 10.1016/j.rbmo.2009.12.011
35.
DimitrovR, KyurkchievD, TimevaT, et al.First-trimester human decidua contains a population of mesenchymal stem cells. Fertil Steril, 2010; 93:210–219; doi: 10.1016/j.fertnstert.2008.09.061
36.
NingG, GuoX, ZhuK, et al.Human decidual mesenchymal stem cells obtained from early pregnancy attenuate bleomycin-induced lung fibrosis by inhibiting inflammation and apoptosis. Int Immunopharmacol, 2024; 142:113224; doi: 10.1016/j.intimp.2024.113224
37.
BüyükbayrakEE, GündoğduN, GürkanN, et al.Immunological effects of human decidual mesenchymal stem cells in spontaneous and recurrent abortions. J Reprod Immunol, 2024; 162:104193; doi: 10.1016/j.jri.2024.104193
38.
FuQ, ManX, YuM, et al.Human decidua mesenchymal stem cells regulate decidual natural killer cell function via interactions between collagen and leukocyte-associated immunoglobulin-like receptor 1. Mol Med Rep, 2017; 16:2791–2798; doi: 10.3892/mmr.2017.6921
39.
ZhouH, ZhouJ, LiuS, et al.Hsa-miR-532-3p protects human decidual mesenchymal stem cells from oxidative stress in recurrent spontaneous abortion via targeting KEAP1. Redox Biol, 2025; 80:103508; doi: 10.1016/j.redox.2025.103508
40.
AbumareeMH, AbomarayFM, AlshehriNA, et al.Phenotypic and functional characterization of mesenchymal stem/multipotent stromal cells from decidua parietalis of human term placenta. Reprod Sci, 2016; 23:1193–1207; doi: 10.1177/1933719116632924
41.
Muñoz-FernándezR, De La MataC, RequenaF, et al.Human predecidual stromal cells are mesenchymal stromal/stem cells and have a therapeutic effect in an immune-based mouse model of recurrent spontaneous abortion. Stem Cell Res Ther, 2019; 10:177; doi: 10.1186/s13287-019-1284-z
42.
MasudaH, AnwarSS, BühringHJ, et al.A novel marker of human endometrial mesenchymal stem-like cells. Cell Transplant, 2012; 21:2201–2214; doi: 10.3727/096368911X637362
43.
LeñeroC, BowlesAC, CorreaD, et al.Characterization and response to inflammatory stimulation of human endometrial-derived mesenchymal stem/stromal cells. Cytotherapy, 2022; 24:124–136; doi: 10.1016/j.jcyt.2021.07.005
44.
DominiciM, Le BlancK, MuellerI, et al.Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy, 2006; 8:315–317; doi: 10.1080/14653240600855905
45.
de Miguel-GómezL, López-MartínezS, Francés-HerreroE, et al.Stem cells and the endometrium: From the discovery of adult stem cells to pre-clinical models. Cells, 2021; 10:595; doi: 10.3390/cells10030595
MaciasMI, GrandeJ, MorenoA, et al.Isolation and characterization of true mesenchymal stem cells derived from human term decidua capable of multilineage differentiation into all 3 embryonic layers. Am J Obstet Gynecol, 2010; 203:495.e9–495.e23; doi: 10.1016/j.ajog.2010.06.045
48.
Dos SantosF, AndradePZ, BouraJS, et al.Ex vivo expansion of human mesenchymal stem cells: A more effective cell proliferation kinetics and metabolism under hypoxia. J Cell Physiol, 2010; 223:27–35; doi: 10.1002/jcp.21987
49.
HuangYC, YangZM, ChenXH, et al.Isolation of mesenchymal stem cells from human placental decidua basalis and resistance to hypoxia and serum deprivation. Stem Cell Rev Rep, 2009; 5:247–255; doi: 10.1007/s12015-009-9069-x
50.
SerranoLJ, de la TorreP, LirasA, et al.Cell therapy for factor V deficiency: An approach based on human decidua mesenchymal stem cells. Biomed Pharmacother, 2021; 142:112059; doi: 10.1016/j.biopha.2021.112059
51.
HanZB, WangYW, WangT, et al.Isolation and biological characteristics of mesenchymal stem cells derived from human placenta decidua basalis. Zhongguo Shi Yan Xue Ye Xue Za Zhi, 2013; 21:754–759.
52.
LiuL, ZhaoG, FanH, et al.Mesenchymal stem cells ameliorate Th1-induced pre-eclampsia-like symptoms in mice via the suppression of TNF-α expression. PLoS One, 2014; 9:e88036; doi: 10.1371/journal.pone.0088036
53.
AkhterW, NakhleJ, VaillantL, et al.Transfer of mesenchymal stem cell mitochondria to CD4(+) T cells contributes to repress Th1 differentiation by downregulating T-bet expression. Stem Cell Res Ther, 2023; 14:12; doi: 10.1186/s13287-022-03219-x
54.
LiY, ZhangD, XuL, et al.Cell-cell contact with proinflammatory macrophages enhances the immunotherapeutic effect of mesenchymal stem cells in two abortion models. Cell Mol Immunol, 2019; 16:908–920; doi: 10.1038/s41423-019-0204-6
55.
AbomarayFM, Al JumahMA, KalionisB, et al.Human chorionic villous mesenchymal stem cells modify the functions of human dendritic cells, and induce an anti-inflammatory phenotype in CD1+ dendritic cells. Stem Cell Rev Rep, 2015; 11:423–441; doi: 10.1007/s12015-014-9562-8
56.
CoppG, RobbKP, ViswanathanS. Culture-expanded mesenchymal stromal cell therapy: Does it work in knee osteoarthritis? A pathway to clinical success. Cell Mol Immunol, 2023; 20:626–650; doi: 10.1038/s41423-023-01020-1
57.
DeviA, PahujaI, SinghSP, et al.Revisiting the role of mesenchymal stem cells in tuberculosis and other infectious diseases. Cell Mol Immunol, 2023; 20:600–612; doi: 10.1038/s41423-023-01028-7
58.
GiacominiC, GranéliC, HicksR, et al.The critical role of apoptosis in mesenchymal stromal cell therapeutics and implications in homeostasis and normal tissue repair. Cell Mol Immunol, 2023; 20:570–582; doi: 10.1038/s41423-023-01018-9
59.
AbumareeMH, Al HarthyS, Al SubayyilAM, et al.Decidua basalis mesenchymal stem cells favor inflammatory M1 macrophage differentiation in vitro. Cells, 2019; 8:173; doi: 10.3390/cells8020173
60.
YangX, DeviantiM, YangYH, et al.Endometrial mesenchymal stem/stromal cell modulation of T cell proliferation. Reproduction, 2019; 157:43–52; doi: 10.1530/REP-18-0266
61.
ZhengS, ShiA, HillS, et al.Decidual mesenchymal stem/stromal cell-derived extracellular vesicles ameliorate endothelial cell proliferation, inflammation, and oxidative stress in a cell culture model of preeclampsia. Pregnancy Hypertens, 2020; 22:37–46; doi: 10.1016/j.preghy.2020.07.003
62.
AghajanovaL, HorcajadasJA, EstebanFJ, et al.The bone marrow-derived human mesenchymal stem cell: Potential progenitor of the endometrial stromal fibroblast. Biol Reprod, 2010; 82:1076–1087; doi: 10.1095/biolreprod.109.082867
63.
YiJZ, ChenZH, XuFH, et al.Interferon-γ suppresses the proliferation and migration of human placenta-derived mesenchymal stromal cells and enhances their ability to induce the generation of CD4(+)CXCR5(+)Foxp3(+)Treg subset. Cell Immunol, 2018; 326:42–51; doi: 10.1016/j.cellimm.2017.07.009
64.
ChenG, YueA, RuanZ, et al.Comparison of biological characteristics of mesenchymal stem cells derived from maternal-origin placenta and Wharton’s jelly. Stem Cell Res Ther, 2015; 6:228; doi: 10.1186/s13287-015-0219-6
65.
ChoiYS, ParkYB, HaCW, et al.Different characteristics of mesenchymal stem cells isolated from different layers of full term placenta. PLoS One, 2017; 12:e0172642; doi: 10.1371/journal.pone.0172642
66.
LucasES, DyerNP, MurakamiK, et al.Loss of endometrial plasticity in recurrent pregnancy loss. Stem Cells, 2016; 34:346–356; doi: 10.1002/stem.2222
67.
KhanjaniS, KhanmohammadiM, ZarnaniAH, et al.Comparative evaluation of differentiation potential of menstrual blood- versus bone marrow-derived stem cells into hepatocyte-like cells. PLoS One, 2014; 9:e86075; doi: 10.1371/journal.pone.0086075
68.
NagaseT, UenoM, MatsumuraM, et al.Pericellular matrix of decidua-derived mesenchymal cells: A potent human-derived substrate for the maintenance culture of human ES cells. Dev Dyn, 2009; 238:1118–1130; doi: 10.1002/dvdy.21944
69.
FukusumiH, ShofudaT, KanematsuD, et al.Feeder-free generation and long-term culture of human induced pluripotent stem cells using pericellular matrix of decidua derived mesenchymal cells. PLoS One, 2013; 8:e55226; doi: 10.1371/journal.pone.0055226
70.
GharibehN, Aghebati-MalekiL, MadaniJ, et al.Cell-based therapy in thin endometrium and Asherman syndrome. Stem Cell Res Ther, 2022; 13:33; doi: 10.1186/s13287-021-02698-8
71.
ZhouZ, WangH, ZhangX, et al.Defective autophagy contributes to endometrial epithelial-mesenchymal transition in intrauterine adhesions. Autophagy, 2022; 18:2427–2442; doi: 10.1080/15548627.2022.2038994
72.
LiangY, ShuaiQ, ZhangX, et al.Incorporation of decidual stromal cells derived exosomes in sodium alginate hydrogel as an innovative therapeutic strategy for advancing endometrial regeneration and reinstating fertility. Adv Healthc Mater, 2024; 13:e2303674; doi: 10.1002/adhm.202303674
73.
ZhangL, LiY, GuanCY, et al.Therapeutic effect of human umbilical cord-derived mesenchymal stem cells on injured rat endometrium during its chronic phase. Stem Cell Res Ther, 2018; 9:36; doi: 10.1186/s13287-018-0777-5
74.
WijayaJC, KhanabdaliR, GeorgiouHM, et al.Functional changes in decidual mesenchymal stem/stromal cells are associated with spontaneous onset of labour. Mol Hum Reprod, 2020; 26:636–651; doi: 10.1093/molehr/gaaa045
75.
KaipeH, CarlsonLM, ErkersT, et al.Immunogenicity of decidual stromal cells in an epidermolysis bullosa patient and in allogeneic hematopoietic stem cell transplantation patients. Stem Cells Dev, 2015; 24:1471–1482; doi: 10.1089/scd.2014.0568
76.
RingdenO, BayganA, RembergerM, et al.Placenta-derived decidua stromal cells for treatment of severe acute graft-versus-host disease. Stem Cells Transl Med, 2018; 7:325–331; doi: 10.1002/sctm.17-0167
77.
SadeghiB, RembergerM, GustafssonB, et al.Long-term follow-up of a pilot study using placenta-derived decidua stromal cells for severe acute graft-versus-host disease. Biol Blood Marrow Transplant, 2019; 25:1965–1969; doi: 10.1016/j.bbmt.2019.05.034
78.
LiZ, YanG, DiaoQ, et al.Transplantation of human endometrial perivascular cells with elevated CYR61 expression induces angiogenesis and promotes repair of a full-thickness uterine injury in rat. Stem Cell Res Ther, 2019; 10:179; doi: 10.1186/s13287-019-1272-3
79.
ChenK, BaiL, LuJ, et al.Human decidual mesenchymal stem cells obtained from early pregnancy improve cardiac revascularization postinfarction by activating ornithine metabolism. Front Cardiovasc Med, 2022; 9:837780; doi: 10.3389/fcvm.2022.837780
80.
SubramaniP, KannaiyanJ, KhareS, et al.Toxicity, safety, and efficacy studies on mesenchymal stem cells derived from decidua basalis in Wistar albino rats by intravenous and subcutaneous routes. Curr Issues Mol Biol, 2022; 44:4045–4058; doi: 10.3390/cimb44090277
81.
BasmaeilYS, BahattabE, AlshabibiMA, et al.Human decidua basalis mesenchymal stem/stromal cells reverse the damaging effects of high level of glucose on endothelial cells in vitro. J Cell Mol Med, 2021; 25:1838–1850; doi: 10.1111/jcmm.15248
82.
BravoB, GallegoMI, FloresAI, et al.Restrained Th17 response and myeloid cell infiltration into the central nervous system by human decidua-derived mesenchymal stem cells during experimental autoimmune encephalomyelitis. Stem Cell Res Ther, 2016; 7:43; doi: 10.1186/s13287-016-0304-5
83.
SuJL, MaK, ZhangCP, et al.Effect of human decidua mesenchymal stem cells-derived exosomes on the function of high glucose-induced senescent human dermal fibroblasts and its possible mechanism. Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi, 2022; 38:170–183.
84.
TanJ, LiP, WangQ, et al.Autologous menstrual blood-derived stromal cells transplantation for severe Asherman’s syndrome. Hum Reprod, 2016; 31:2723–2729; doi: 10.1093/humrep/dew235
85.
MaH, LiuM, LiY, et al.Intrauterine transplantation of autologous menstrual blood stem cells increases endometrial thickness and pregnancy potential in patients with refractory intrauterine adhesion. J Obstet Gynaecol Res, 2020; 46:2347–2355; doi: 10.1111/jog.14449
86.
HuJ, SongK, ZhangJ, et al.Effects of menstrual blood-derived stem cells on endometrial injury repair. Mol Med Rep, 2019; 19:813–820; doi: 10.3892/mmr.2018.9744
87.
ZhaoM, ChiF, ZhangT, et al.Human menstrual blood-derived mesenchymal stem cells regulation of the EGF/Ras p21 pathway as a potential therapeutic target for thin endometrium. Ann Transl Med, 2021; 9:1476; doi: 10.21037/atm-21-4652
88.
ChenL, GuoL, ChenF, et al.Transplantation of menstrual blood-derived mesenchymal stem cells (MbMSCs) promotes the regeneration of mechanical injuried endometrium. Am J Transl Res, 2020; 12:4941–4954.
89.
MaC, YiC, GuanC. Menstrual blood-derived mesenchymal stem cells improve endometrial receptivity in a mouse model of embryonic implantation dysfunction. Cell Reprogram, 2025; 27:124–133; doi: 10.1089/cell.2024.0071
90.
ZhangS, ChangQ, LiP, et al.Concentrated small extracellular vesicles from menstrual blood-derived stromal cells improve intrauterine adhesion, a pre-clinical study in a rat model. Nanoscale, 2021; 13:7334–7347; doi: 10.1039/d0nr08942g
ZhangS, LiP, YuanZ, et al.Platelet-rich plasma improves therapeutic effects of menstrual blood-derived stromal cells in rat model of intrauterine adhesion. Stem Cell Res Ther, 2019; 10:61; doi: 10.1186/s13287-019-1155-7
93.
PanY, ChangM, ZhangW, et al.Enhanced improvement of menstrual blood derived endometrial stem cells encapsulated in cross-linked hyaluronic acid on intrauterine adhesions. Reprod Sci, 2025; 32:2703–2716; doi: 10.1007/s43032-025-01928-1
94.
ChenK, GaoY, XiaN, et al.Long-term therapeutic effects of allogeneic mesenchymal stem cell transplantation for intrauterine adhesions. Stem Cell Res Ther, 2024; 15:499; doi: 10.1186/s13287-024-04100-9
95.
WuM, WuS, TanS, et al.VitroGel-loaded human MenSCs promote endometrial regeneration and fertility restoration. Front Bioeng Biotechnol, 2023; 11:1310149; doi: 10.3389/fbioe.2023.1310149
96.
SugawaraK, HamataniT, YamadaM, et al.Derivation of human decidua-like cells from amnion and menstrual blood. Sci Rep, 2014; 4:4599; doi: 10.1038/srep04599
97.
CervellóI, Gil-SanchisC, MasA, et al.Human endometrial side population cells exhibit genotypic, phenotypic and functional features of somatic stem cells. PLoS One, 2010; 5:e10964; doi: 10.1371/journal.pone.0010964
98.
LiaoZ, LiuC, WangL, et al.Therapeutic role of mesenchymal stem cell-derived extracellular vesicles in female reproductive diseases. Front Endocrinol (Lausanne), 2021; 12:665645; doi: 10.3389/fendo.2021.665645
99.
De MiguelMP, AlcainaY, de la MazaDS, et al.Cell metabolism under microenvironmental low oxygen tension levels in stemness, proliferation and pluripotency. Curr Mol Med, 2015; 15:343–359; doi: 10.2174/1566524015666150505160406
100.
ZhengL, PanC, MaD, et al.Overexpression of Nrf2 in bone marrow mesenchymal stem cells promotes B-cell acute lymphoblastic leukemia cells invasion and extramedullary organ infiltration through stimulation of the SDF-1/CXCR4 axis. Front Pharmacol, 2024; 15:1393482; doi: 10.3389/fphar.2024.1393482
101.
BeegleJR, MagnerNL, KalomoirisS, et al.Preclinical evaluation of mesenchymal stem cells overexpressing VEGF to treat critical limb ischemia. Mol Ther Methods Clin Dev, 2016; 3:16053; doi: 10.1038/mtm.2016.53
102.
GuoJ, ShiX, YuF, et al.Adjuvants to prevent reformation of adhesions following adhesiolysis for Asherman syndrome: A systematic review and meta-analysis. Hum Fertil (Camb), 2023; 26:797–814; doi: 10.1080/14647273.2023.2254492
103.
ZaripovaLN, MidgleyA, ChristmasSE, et al.Mesenchymal stem cells in the pathogenesis and therapy of autoimmune and autoinflammatory diseases. IJMS, 2023; 24:16040; doi: 10.3390/ijms242216040
104.
ZhouW, WangJ, DingL, et al.Autophagy inhibition enhances antifibrotic potential of placental mesenchymal stem cells of fetal origin via regulating TGF-β1 mediated protein degradation of HGF. Sci Rep, 2025; 15:13805; doi: 10.1038/s41598-025-97054-8
ZhangG, ZouX, MiaoS, et al.The anti-oxidative role of micro-vesicles derived from human Wharton-Jelly mesenchymal stromal cells through NOX2/gp91(phox) suppression in alleviating renal ischemia-reperfusion injury in rats. PLoS One, 2014; 9:e92129; doi: 10.1371/journal.pone.0092129
107.
SongY, LvS, WangF, et al.Overexpression of BMP-7 reverses TGF-β1-induced epithelial-mesenchymal transition by attenuating the Wnt3/β-catenin and TGF-β1/Smad2/3 signaling pathways in HK-2 cells. Mol Med Rep, 2020; 21:833–841; doi: 10.3892/mmr.2019.10875
108.
BasmaeilY, SubayyilAA, KulaybHB, et al.Partial inhibition of epithelial-to-mesenchymal transition (EMT) phenotypes by placenta-derived DBMSCs in human breast cancer cell lines, in vitro. Cells, 2024; 13:2131; doi: 10.3390/cells13242131
109.
ShiY, WangY, LiQ, et al.Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases. Nat Rev Nephrol, 2018; 14:493–507; doi: 10.1038/s41581-018-0023-5
110.
KhouryM, Alcayaga-MirandaF, IllanesSE, et al.The promising potential of menstrual stem cells for antenatal diagnosis and cell therapy. Front Immunol, 2014; 5:205; doi: 10.3389/fimmu.2014.00205
LiuZ, ShiQW, XuJ. Research advances in role of mesenchymal stem cells derived exosomes in wound repair. Acad J Chin PLA Med Sch, 2022; 43:896–900.
113.
ChenL, ZhangC, ChenL, et al.Human menstrual blood-derived stem cells ameliorate liver fibrosis in mice by targeting hepatic stellate cells via paracrine mediators. Stem Cells Transl Med, 2017; 6:272–284; doi: 10.5966/sctm.2015-0265
114.
Shakouri-MotlaghA, O’ConnorAJ, BrenneckeSP, et al.Extracellular vesicles support increased expansion of mesenchymal stromal cells on fetal membrane-derived decellularized extracellular matrix. Cell Tissue Res, 2025; 399:323–336; doi: 10.1007/s00441-024-03946-y
115.
ZhengJ, YangB, LiuS, et al.Applications of exosomal miRNAs from mesenchymal stem cells as skin boosters. Biomolecules, 2024; 14:459; doi: 10.3390/biom14040459
116.
DalirfardoueiR, JamialahmadiK, JafarianAH, et al.Promising effects of exosomes isolated from menstrual blood-derived mesenchymal stem cell on wound-healing process in diabetic mouse model. J Tissue Eng Regen Med, 2019; 13:555–568; doi: 10.1002/term.2799
117.
LiuF, HuS, WangS, et al.Cell and biomaterial-based approaches to uterus regeneration. Regen Biomater, 2019; 6:141–148; doi: 10.1093/rb/rbz021
118.
PiuzziNS, EmaraA, ChahlaJ, et al.Ethical and practical considerations for integrating cellular (“Stem Cell”) therapy into clinical practice. Curr Rev Musculoskelet Med, 2020; 13:525–529; doi: 10.1007/s12178-020-09647-7
119.
YamaguchiN, HorioE, SonodaJ, et al.Immortalization of mesenchymal stem cells for application in regenerative medicine and their potential risks of tumorigenesis. IJMS, 2024; 25:13562; doi: 10.3390/ijms252413562
120.
KhanG. Stem cell nanotechnology applications as drug delivery systems for cancer therapy: A new era in targeted treatment. Curr Pharm Des, 2025:579–587; doi: 10.2174/0113816128379044250620122425
